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Background: Despite the burden of acute respiratory illnesses (ARI) among Aboriginal and Torres Strait Islander
children being a substantial cause of childhood morbidity and associated costs to families, communities and the
health system, data on disease burden in urban children are lacking. Consequently evidence-based decision-making,
data management guidelines, health resourcing for primary health care services and prevention strategies are lacking.
This study aims to comprehensively describe the epidemiology, impact and outcomes of ARI in urban Aboriginal and
Torres Strait Islander children (hereafter referred to as Indigenous) in the greater Brisbane area.
Methods/Design: An ongoing prospective cohort study of Indigenous children aged less than five years registered
with a primary health care service in Northern Brisbane, Queensland, Australia. Children are recruited at time of
presentation to the service for any reason. Demographic, epidemiological, risk factor, microbiological, economic
and clinical data are collected at enrolment. Enrolled children are followed for 12 months during which time ARI
events, changes in child characteristics over time and monthly nasal swabs are collected. Children who develop an
ARI with cough as a symptom during the study period are more intensely followed-up for 28 (±3) days including
weekly nasal swabs and parent completed cough diary cards. Children with persistent cough at day 28 post-ARI
are reviewed by a paediatrician.
Discussion: Our study will be one of the first to comprehensively evaluate the natural history, epidemiology,
aetiology, economic impact and outcomes of ARIs in this population. The results will inform studies for the
development of evidence-based guidelines to improve the early detection, prevention and management of
chronic cough and setting of priorities in children during and after ARI.
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Respiratory illnesses (RI) in Aboriginal and Torres Strait
Islander people (here forth referred to as Indigenous)
are common, serious and important. Nationally, diseases
of the respiratory system, although ranked 4th as the
cause of death in Indigenous infants, are the commonest
cause of preventable deaths [1]. Respiratory disease is
the second most common reason for hospitalisation
among Indigenous Australians (after renal dialysis) [1].
Lower acute RIs (ARI) account for the greatest number
of hospitalisations in young Indigenous children aged
under-5 years [1]. Also, the prevalence of serious chronic
RIs such as non-cystic fibrosis (CF) bronchiectasis is
high (one in 68 children) in Indigenous children living
in remote regions [2] and this is associated with repeated
episodes of hospitalised RIs [3]. Thus, Indigenous children
bear a disproportionate burden of acute and chronic
lower RIs [4, 5].
Worldwide, many factors have been identified as
increasing the risk of developing ARI. Most of these pre-
dictors are inherently related to both the prenatal and
antenatal periods and the first five years of life. These
include overcrowding, malnutrition, exposure to tobacco
smoke, young maternal age, low birth weight, anaemia,
poverty, illiteracy, overcrowding, parental smoking, pol-
lution, socio economic status, social behaviours, cultural
factors and family history [6–9]. Despite the burden of
ARI in Australian Indigenous children, there are limited
studies that have examined these factors at the commu-
nity level.
To date the focus on ARI in Australian Indigenous
children has been almost entirely on children living in rural
and remote regions of Australia, with no community-based
data on disease and its social and economic impacts in
their urban contemporaries. This is despite the fact that
more Indigenous children live in urban Australia and
socio-economic and health indices are consistently lower
for urban Indigenous communities when compared to
non-Indigenous populations [1]. Further, there are few
studies that have examined differences in ARI incidence
and predictors between urban Indigenous and non-
Indigenous children at the community level, particularly
in communities that are socio-economically and geo-
graphically similar. A community-based Australian study
in west Sydney estimated that the reported rate of
pneumonia in non-Indigenous children was 7.5/1000,
compared to 12/1000 in Indigenous Children [10]. A
survey in the Australian Capital Territory reported that
Indigenous children had a higher prevalence of recent
wheeze (21 %), wheeze with colds (36 %), dry cough at
night (27 %) and parent-reported asthma (24 %) compared
to 15 %, 23 %, 19 % and 15 % respectively in non- Indi-
genous Islander children [11]. Maternal factors and the
external environment have been linked to infertility,early pregnancy loss, premature labour and low birth-
weight. Children with low birth weight are six times
more likely to be hospitalised with ARI than children
with normal birth weight [12, 13].
In addition to the above, ARIs are also associated with
social and economic costs. Those relevant to the urban
Indigenous community are unknown. In non-Indigenous
communities the only the Australian studies to investi-
gate the cost associated with ARI have been conducted
in cohorts of Melbourne pre-school aged children [14,
15]. In the first study of children aged 12 – 71 months
that focussed on influenza like illness, the average cost
of community-managed episodes (without hospitalisa-
tion) was $241 (95 % CI $191 - $291). The key cost
drivers were carer time away from usual activities caring
for the ill child (70 % of costs), use of non-prescription
medications (5.4 %), and general practice visits (5.0 %).
The patient and family met 87 % of total costs. In a fur-
ther study focussing on viral respiratory illnesses, the
mean cost of ARIs was AU$309 (95 % CI $263 to $354).
Influenza illnesses had a mean cost of AU$904 and RSV,
AU$304. These studies were however conducted in a
population with relatively high social and economic indi-
ces. Data was not collected on the impact of these
illnesses on health service providers themselves.
The lack of data on urban Indigenous populations has
been identified as one important barrier to Closing the
Gap initiatives [16]. Although more than half of Australia’s
Aboriginal and Torres Strait Islander population live in
urban and regional centres, most research and commen-
taries address the health and social issues of remote com-
munities [17]. In the absence of such data, we plan to
conduct a study that addresses some of these gaps. Here,
we present our protocol for a longitudinal, community-
based, cohort study of ARI in urban children aged < 5 years
presenting to a presenting to a primary health care centre.
Aims and objectives
This study aims to comprehensively describe the epidemi-
ology, aetiology, social and economic impact and out-
comes of ARI in children aged less than 5 years registered
with an urban primary health care service. Our primary
objectives are to determine the incidence and predictors
of ARI amongst urban Indigenous children over 12 months
of child observation. Our secondary objectives are to: a)
determine the prevalence of chronic cough (≥4 weeks dur-
ation) following an ARI; b) determine the direct and indir-
ect economic costs of ARI, and; c) examine nasal carriage
of respiratory viruses and bacteria over a 12 month period.
Methods/Design
Setting
This study is being undertaken at Murri Medical
(MM), a not-for-profit, Aboriginal owned and operated
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a northern suburb of Brisbane, Queensland, Australia.
MM provides services to the Moreton Bay Regional
Council Area, a region with a comparatively lower
socio-economic status than inner Brisbane areas [18],
and has approximately 9500 registered clients of which
approximately two-thirds identify as Aboriginal and/or
Torres Strait Islander.
Research team
The research team responsible for inception, implemen-
tation, actioning and management of the protocol in-
cludes paediatric specialists in the field of respiratory
medicine, microbiology, epidemiology, nursing, health
economics and biostatistics. Study specific research offi-
cers (Aboriginal women) undertake recruitment, data
collection, complete participant follow-up, data entry
and attend to daily study requirements such as booking
of specialist reviews. A paediatrician is responsible for
the review and assessment of children who develop
chronic cough following an ARI.
Study design
An ongoing prospective cohort study of Indigenous chil-
dren aged less than 5 years registered with MM with
12 months of observation per child. Children who develop
cough as a symptom at any time over the 12 months are
subsequently followed weekly for four weeks to ascertain
costs and cough outcomes. Participation in the study has
no bearing on the medical care provided to children at
MM, which is conducted separately and in accordance
with clinic policies and procedures. Parents are also en-
couraged to practice normal healthcare seeking behaviours
throughout the duration of their participation.
Our primary endpoint is an ARI defined as an acute
illness (i.e. less than 14 days duration) with cough as
symptom with or without any accompanying symptoms.
Our secondary endpoints are: a) chronic cough defined as
cough duration of greater than 28 days with no cessation
of cough lasting more than 3 days; b) direct and indirect
costs of illness in Australian dollars, and c) detection of
per protocol respiratory viruses and bacteria by polymer-
ase chain reaction (PCR) on nasal swabs.
The study has been approved by Queensland Chil-
dren’s Health Services Human Research Ethics Commit-
tee (HREC/12/QRCH/169), the Medical Research Ethics
Committee of the University of Queensland (2012001395)
and the Human Research Ethics Committee of the
Queensland University of Technology (1300000741).
Recruitment
Recruitment began in February 2013 and is planned to
continue until June 2015 to account for annual variation
in ARI incidence and aetiology. All children aged lessthan 5 years presenting to MM during business hours
(Monday to Friday, 0830 – 1700 h) are recorded on a
detailed screening log by the research assistant. This log
contains de-identified demographic data as well as the
reason for non-participation in the study (e.g.; ineligible,
refused). Parents/guardians of all children are approached
by an Aboriginal researcher at the time of presentation
to the clinic for assessment of eligibility. Using a plain
language statement or flip chart that explains the study
in detail, written informed consent is obtained from a
parent(s) or carer if they agree to participate.
Inclusion criteria
Children are eligible for the study if: a) they identify as
Aboriginal and/or Torres Strait Islander; b) they are
aged less than five years at time of enrolment; c) they
are registered as a client of MM; d) the parent/guardian
has provided written informed consent, and; e) the par-
ent/guardian is willing and able to complete the protocol
requirements.
Exclusion criteria
Children are excluded from the study if they are planning
to move from the study area in the following 12 months.
Study participation
At enrolment, a dedicated Indigenous research officer
completes a comprehensive questionnaire with the child
and their guardian. (Fig. 1) Parent(s) or carers of enrolled
children are contacted monthly via telephone, email or
home visiting for 12 months. Data collection during these
time points include parent-collected nasal swabs, ARI
events and changes in child characteristics over time.
Children with an ARI at any time during the study (at
presentation or later development of an ARI) are then
intensively followed via weekly follow-up via telephone
and/or email contacts for four weeks including nasal
swabs, and parent-completed cough diary cards. These
contacts are used to ascertain parent reported cough per-
sistence and type, parental absence from work due to their
child’s cough, missed day-care/school due to cough and
whether or not the child’s cough has ceased for a period of
greater than three consecutive days during the follow-up
period. If a child has a persistent cough at day 28, he/she
is reviewed by a paediatrician with expertise in respiratory
medicine at the Queensland Children’s Respiratory Centre
in Brisbane. At this review a comprehensive assessment is
completed in accordance with current cough management
guidelines [19, 20]. Children are managed and investiga-
tions performed as clinically indicated.
Data collection
At enrolment, demographic, epidemiological, cultural,
economic and clinical data are recorded including, but
Fig. 1 Study design
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the presence of any respiratory symptoms, healthcare
utilisation prior to presentation, current and past med-
ical history, medication use, treatment and diagnosis,
clinical investigation results, socioeconomic status and
direct and indirect cost of ARI. Historical variables and
those previously described as risk factors for paediatric
ARI and lung disease are also collected, including; past
respiratory history, familial history, asthma and lung
disease, household information (e.g. number of occu-
pants), pregnancy related factors (e.g. gestational age
and birth weight), tobacco smoke exposure and cultural
factors (e.g. connection to traditional lands and cul-
ture). A bilateral anterior nasal swab is collected at
enrolment.
For the economic data, both direct and indirect costs
to the family, health service provider and employer/community are collected. (Table 1) Time spent by the
providers and associated activities will be measured
either as resources/inputs used or the time spent by the
health care personnel. Where such data may not be
available, as is often the case, mainstream data can be
adopted using Indigenous templates [21], or expert
judgement or explicit framework maybe used. The valu-
ation of the resources used will involve the use of unit
costs from the Medicare Benefits Schedule, Pharma-
ceutical Benefits Scheme and Aboriginal community
expert judgements on certain activities [22, 23].
Monthly data collection includes: parent(s) or carers
of enrolled children being contacted monthly via
telephone, email or home visiting for a period of
12 months. Data collection during this time includes
parent-collected nasal swabs, ARI events and changes
in child characteristics over time.
Table 1 Direct and indirect cost of ARI
Family Employers/Community Healthcare Service
Medication usage Time spent seeking healthcare Medication usage
- includes over-the-counter and prescribed
medications
- Time off work with pay - includes over-the-counter and prescribed medications
- Time off work with pay lost
- Time off usual activity
Healthcare seeking travel costs Extra time spent caring for child Healthcare service utilisation
- includes ambulance and community
transport services
- Time off work with pay - diagnostic tests and complementary/alternative therapies
- Time off work with pay lost - distinguishes between public and private, paid and bulk
billed services
- Time off usual activity
Time spent seeking healthcare Healthcare seeking travel costs Healthcare seeking travel costs
- Time off work with pay - includes ambulance and community
transport services
- includes ambulance and community transport services
- Time off work with pay lost
- Time off usual activity
Extra time spent caring for child
- Time off work with pay
- Time off work with pay lost
- Time off usual activity
Missed childcare/school
Missed planned activities
- child and others
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The nasal swabs are stored at −80 °C at the Queensland
Paediatric Infectious Diseases Laboratory, Royal Chil-
dren’s Hospital, Brisbane. Nasal swabs are thawed and
processed in batches for viral and bacterial identification
by polymerase chain reaction (PCR) testing as per our
previously described methods.
PCR testing for M. pneumoniae, S.pneumoniae, Non
Typable Haemophilis influenzae (NTHi) and M. cattar-
halis is conducted and a 16S signature sequence to
detect all strains of Chlamydiales is used as an initial
screen before + ve specimens are tested for specific C.
trachomatis, C pneumoniae and S. negevensis sequences.
PCR will also be used to detect 17 viruses associated
with the human respiratory tract including; adenovirus,
respiratory syncytial virus, influenza virus types A & B,
parainfluenza virus types 1–3, human metapneumovirus,
human rhinoviruses, human coronaviruses (OC43, 229E,
NL63 + HKU1), human bocavirus and human polyoma-
viruses KI and WU. Specimen extracts to be tested from
each individual will be pooled and will undergo PCR
testing for the above-mentioned respiratory pathogens.
Data handling and storage
Data are collected using paper-based case report forms
and entered into a secure Filemaker Pro V12.0 (Filemaker
Inc, Santa Clara, CA) database. On completion of study
participation, the Chief Investigator reviews all participantfiles and approves them for sign off and storage. All study
folders are stored in a locked secure cabinet accessible
only to study staff unless required by legislative or regula-
tory agencies. Data collected throughout the study are
monitored and participant files checked against source
documents for completeness and accuracy at completion
of each stage.
Sample size
In the absence of published data on the incidence of
respiratory illness, in urban Aboriginal and Torres Strait
Islander children at the community level, calculating a
sample size on a priori evidence is not possible. A study
of urban children living in Melbourne during the winter
months reported an incidence of influenza-like illnesses
of 0.53 episodes per child-month (95 % CI 0.44-0.61)
[24]. If we assume a similar incidence, 242 children will
be sufficient to detect this rate with a 95 % CI and mar-
gin of error of 5.8 %. As the incidence is likely to be
higher, a preliminary analysis will be performed when
120 children are enrolled to determine whether the a
priori sample size can be modified.
Data analysis
Broadly, descriptive and analytical statistical methods will
be utilised including univariate and multivariate logistic
and Poisson regression to identify independent predictors
of study endpoints. Demographic, clinical, laboratory,
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and expressed as proportions and/or means of the
selected characteristics with the corresponding 95 %
Confidence Intervals (CI).
Economic analyses will be done according to estab-
lished methods [25]: including detailed subanalyses of
data that account for epidemiological, social, cultural,
risk factor and microbiological variables.
The primary analysis will be the incidence density of
ARI over a 12-month period. Differences in demo-
graphic, clinical, laboratory and risk factor data between
children who do and do not develop ARI will be
assessed by the normal test for comparisons of means
and χ2 tests for comparison of proportions. The inci-
dence of ARI and the predictors for episodes will be
assessed assuming a Poisson distribution and multivari-
ate analyses performed using Poisson regression
methods. The denominator will be child weeks of obser-
vation, with the number of days of ARI experienced for
each child removed from person-time at risk calculations.
To estimate the cost of ARI illness, the costing ap-
proach will involve following three steps [26]: a) Identifi-
cation of the appropriate resources used, b) Measurement
of resources used; and c) valuation of such resources used.
Identification of the resources or inputs used, such as
health care personnel, transport, consumables, will be
guided by the ARI clinical or care pathway, which will be
used to identify key care activities and associated unit
costs. The pathway will reflect the purpose of the exercise,
identify all the components or elements of the program/
service in a linear manner, and may involve disease pro-
gressions [27]. Some or all of the following type of activ-
ities will be included in the costing, which may differ from
costs in non-ACCHS services: Co-payments for the
pharmaceutical products; transport of clients to and from
clinic /or services, social and cultural issue that clinic staff
with on behalf of client’s e.g. economic hardship, legal
issues. The units of measure of costing data will then be
combined with the unit costs to estimate the cost of each
activity. The costs of the activities will be aggregated to
estimate the cost of illness in Indigenous peoples.
Discussion
To our best of our knowledge, this will be the first
Australian study and one of the few worldwide to com-
prehensively evaluate ARIs and their outcomes in Indi-
genous children living in an urban area. To date, the
focus on ARIs has been almost entirely on children
living in rural and remote regions of Australia, with no
community based data on disease and its social and
economic impacts in urban Indigenous children. Our
prospective cohort study design in conjunction with a
comprehensive clinical, epidemiological, economic and
microbiological collection of data will address issues atboth the time of presentation and during the recovery
phase of cough illness. Data from this study will likely
contribute to future research aiming to develop evidence-
based guidelines to improve the early detection, prevention
and management of chronic cough in children during and
after ARI.
Rationale for study endpoints
Our definition of ARI that incorporates cough as a
symptom is designed to be more specific for events that
are likely to lead to higher morbidity and reflect illnesses
such as bronchiolitis and pneumonia, important pre-
cursors to the development of chronic lung diseases in
children, particularly if recurrent [20]. Monitoring the
development of chronic cough (i.e. > 4 week’s duration)
is therefore a key secondary endpoint given its role as an
indicator of lower airways disease. Enrolling children for
a period of 12 months and incorporating monthly follow
up will enable us to measure changes in predictors (e.g.
child care attendance, changes in breastfeeding and
vaccination status and exposure to tobacco smoke) and
impacts over time.
Our economic endpoints, using a societal perspective,
will include cost to the parent/family, cost to the health
care sector and other sectors of the economy, such as
school attendance and absenteeism from employment
[25]. This will enable a complete analysis of the cost of
illness that incorporates both direct and indirect costs.
Establishing these costs will enable the development of
interventions to reduce the burden of disease that in-
corporate the cost effectiveness of these strategies.
Our microbiological endpoints will provide new infor-
mation on the characteristics of these infections in
urban Indigenous children at the community level given
very few children presenting to primary care settings
with ARI undergo bacterial and viral testing. The collec-
tion of bilateral anterior nasal swabs on all study children
will identify viral and bacterial pathogens associated with
ARI and cough at both the time of enrolment, and at
monthly time points and specialist review. An extended
panel of known respiratory pathogens (previously dis-
cussed) was chosen to ensure that pathogens excluded
from routine respiratory PCR testing were included for
analysis and contribute to the literature on pathogens for
which the association between nasal detection and clinical
illness is still being explored (e.g. polyomaviruses) [28].
Using an extended panel also enhances our ability to ex-
plore viral and bacterial interactions and their effects on
cough outcomes. However, associating viral detection with
current illness is not straight forward as up to 42 % of chil-
dren who have a non-classical virus detected are asymp-
tomatic [29]. Also, co-detection of viruses and/or virus
with bacteria are also commonly found in children with
acute and chronic respiratory illnesses [30, 31].
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search officers are undertaking all recruitment and data
collection in an Indigenous specific primary health care
setting, recruitment and data collection is conducted in
a culturally safe environment. The relationship between
the researcher and participants established with mutual
respect and empathy under an ‘indigenous’ umbrella of
‘unwritten’ respect and trust better known as an indigen-
ous methodology, indigenous way of doing [32].Limitations
Selection bias
A difference may exist between families who seek care
through MM and those who attend other primary care
facilities. As MM services an area of predominantly low
socio-economic status, ARI incidence and its predictors/
outcomes may be higher than other settings. It is plausible
that parents of children with recurrent ARI are more likely
to enrol and complete the study, potentially overestimat-
ing the prevalence of chronic cough at day 28. Similarly
children with existing undiagnosed chronic lung disease
may be enrolled in the study also inflating the prevalence
of chronic cough. However, the identification of these
children will be an important outcome for the child and
his/her family. Our extensive baseline data collection and
comprehensive assessment of child at specialist review will
allow assessment of these potential biases.
There is also the potential of bias derived from loss-
to-follow-up, particularly as those who complete the
study may differ from those who do not. However it is
expected that this will be limited due to the relationship
between the researcher and participants established with
mutual respect and empathy under an ‘Indigenous’ um-
brella of ‘unwritten’ respect and trust better known as an
Indigenous methodology, Indigenous way of doing [32].
Early specialist referral (within 2 weeks of day 28) as part
of the study is likely to underestimate costs in children
with chronic cough and is therefore, more likely to repre-
sent the cost-of-illness incurred with early intervention.
However, retrospective collection of cough persistence
and healthcare utilisation data at the time of enrolment
will allow for assessment of such a bias. The collection of
detailed symptom, treatment and clinical data, as well as
the collection of study specific anterior nasal swabs will
minimise the effect of any potential bias.Measurement bias
Clinician diagnosis may vary between doctors at the
clinic due to experience and expertise consequently
diagnosis, clinical investigations performed and treat-
ment given may vary between clinicians. Our collection
of detailed symptom, treatment and clinical data will
facilitate standardising study specific case definitions.Proxy reporting by parents of cough persistence and type
via a diary card using a VCD score was the chosen method
for recording cough data during ARI follow up [33]. Even
though some misclassification of cough may occur, Chang
et al. [34] report that VCD diary cards have the highest
correlation to cough frequency when measured objectively
and hence, can be used in the absence of practical objective
measures to evaluate cough severity and persistence. At
specialist review (where required), both the parent and
treating physician report on cough type allowing for the
assessment of inter-rater reliability and the potential for
derived bias Through employing a small team of study
specific respiratory specialists from the same centre, the
potential for bias derived from inconsistency of diagnosis
at the time of specialist review will be minimised.
Conclusion
ARIs are an inadequately researched cause of morbidity
in urban Indigenous children. This study will describe
the natural history, epidemiology, aetiology, outcomes
and cost of ARI in urban Indigenous children. The re-
sults will inform studies for evidence-based guidelines to
improve the early detection, prevention and manage-
ment of chronic cough in children during and after ARI.
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